Aura Biosciences, Inc.AURANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+29.0%
5Y CAGR+38.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+29.0%/yr
Annual compound
5Y CAGR
+38.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$90.74M+23.8%
2024$73.30M+14.6%
2023$63.94M+51.4%
2022$42.24M+67.9%
2021$25.16M+39.5%
2020$18.04M-5.6%
2019$19.11M-